A new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseases
Neurodegenerative disorders including Alzheimer′s disease are characterized by chronic inflammation in the central nervous system. The two main glial types involved in inflammatory reactions are microglia and astrocytes. While these cells normally protect neurons by providing nutrients and growth fa...
Main Authors: | Jocelyn M Madeira, Stephanie M Schindler, Andis Klegeris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=3;spage=391;epage=393;aulast=Madeira |
Similar Items
-
Electroacupuncture in the repair of spinal cord injury: inhibiting the Notch signaling pathway and promoting neural stem cell proliferation
by: Xin Geng, et al.
Published: (2015-01-01) -
Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury
by: Iris K Salgado, et al.
Published: (2015-01-01) -
Dysfunctional glia: contributors to neurodegenerative disorders
by: Marta Sidoryk-Wegrzynowicz, et al.
Published: (2021-01-01) -
Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models
by: Hanyu Yang, et al.
Published: (2020-02-01) -
Low-Dose Dextromethorphan for the Treatment of Fibromyalgia Pain: Results from a Longitudinal, Single-Blind, Placebo-Controlled Pilot Trial
by: Mueller C, et al.
Published: (2021-01-01)